Tuberculosis Costs the World $1.35 Trillion Annually
New research indicates tuberculosis drains 0.8% of the world's economic potential annually, disproportionately affecting low- and middle-income countries.
Tag: TB tuberculosis
All
Latest
Tuberculosis Costs the World $1.35 Trillion Annually
New research indicates tuberculosis drains 0.8% of the world’s economic potential annually, disproportionately affecting low- and middle-income countries.
Read More
Inhaled Nanomedicine Targets Tuberculosis in the Lungs
A new delivery system allows four standard tuberculosis medications to be inhaled directly into the respiratory tract, potentially reducing side effects and improving treatment adherence.
Read More
Tuberculosis Survivors Face Elevated Mortality Risk for 14 Years After Treatment
Even after successful treatment completion, tuberculosis patients experience higher rates of death from respiratory and cardiovascular causes.
Read More
Test Identifies Active, Infectious Tuberculosis
On World Tuberculosis Day, March 24, a test developed by UC Davis Health could soon speed up diagnosis and help prevent its spread.
Read More
Tuberculosis Mycobacteria Use Stealth Mechanism to Evade Immune System
Tuberculosis-causing mycobacteria stiffen cell membranes to avoid destruction, but the discovery opens new pathways for treatment.
Read More
Antibodies Block Bacteria That Cause Tuberculosis
UTSW researchers’ discovery of immune cell activation could lead to prevention tools for tuberculosis and other diseases.
Read More
Comparing Daily vs Weekly Pharmacology for Tuberculosis
A study in Brazil found that a 30-day daily TB preventive therapy regimen was as safe and effective as the standard 90-day weekly regimen.
Read More
Shortening Tuberculosis Treatment via Precision Medicine
Tuberculosis (TB) precision medicine may shorten therapy by using clinical phenotypes to guide stratified treatment with monitoring.
Read More
Co-Infections May Fuel Long COVID
Latent or concurrent infections—especially Epstein-Barr virus and tuberculosis—may drive persistent symptoms in a subset of long COVID patients.
Read More
Novel Drug Candidate for Tuberculosis
A new compound that kills tuberculosis bacteria by inhibiting ATP synthase at a different site than existing drugs like bedaquiline.
Read More
BIDMC Scientists Create Novel TB Vaccine Candidate
An investigational mRNA vaccine protected mice better than the century-old TB vaccine—limiting infection and slowing disease spread.
Read More
New Tuberculosis Treatment Shows Promise
A new compound could offer a breakthrough in the global fight against tuberculosis, history’s deadliest infectious disease.
Read More
New Therapy Benefitted Some Drug-resistant TB Patients
Some patients with pre-extensively drug-resistant TB benefitted from shorter, simpler regimens.
Read More
Smartphone-sized Device Tests for Tuberculosis
A smartphone-sized, battery-powered lab-in-tube assay (LIT) provides a cost-effective tool that can improve TB diagnoses, particularly in resource-limited rural areas.
Read More
Three New Ways To Treat Drug-Resistant Tuberculosis
An international clinical trial has found three new safe and effective drug regimens for tuberculosis that is resistant to rifampin, the most effective of the first-line antibiotics used to treat TB.
Read More
TB or Not TB? Risk Tool Helps Optimize Isolation Practices
Now in use at all Mass General Brigham sites, the tool helps clinicians assess whether infection control precautions can be discontinued.
Read More
Largest Tuberculosis Outbreak is US History Ongoing in Kansas
A tuberculosis outbreak that has infected 67 people in the greater Kansas City metro area is the largest in US history, according to Kansas Dept of Health and Environment.
Read More
CRISPR-TB Blood Test Gets FDA Breakthrough Device Designation
The test uses a molecular diagnostic platform to detect Mycobacterium tuberculosis DNA in blood samples.
Read More
New Guidelines Recommend Shorter All-Oral TB Treatment Regimens
The latest clinical practice guidelines advocate for four- and six-month all-oral regimens for eligible children and adults with drug-susceptible or drug-resistant tuberculosis.
Read More
Fingertip Sweat Test Tracks Antibiotics Use in Tuberculosis Patients
Antibiotics in tuberculosis patients can be accurately monitored through a fingerprint sweat test, offering a less invasive alternative to blood tests, research finds.
Read More
WHO Updates Terminology for Airborne Pathogens
The report introduces the term “infectious respiratory particles” and advocates for moving away from the dichotomy of the previously used terms “aerosols” and “droplets.”
Read More
Break the TB Chain of Transmission on World TB Day 2024
On World TB Day, 24 March 2024, the Forum of International Respiratory Societies (FIRS) calls on all stakeholders, including multilateral agencies, governments, national and local programs, non-governmental organizations, academics, activists and donors to focus on activities that will break the chain of transmission in high-burden settings in order to end tuberculosis (TB).
Read More80% of Tuberculosis Patients Don’t Have Persistent Cough
A study of more than 600,000 individuals shows that 4 in 5 with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
Read More
WHO Launches E-course on Pediatric Tuberculosis Management
On World Children’s Day (Nov 20), the World Health Organization launched a new e-course on the management of tuberculosis in children and adolescents.
Read More